Co-leaders, left, Taylor Riall, MD, PhD, FACS and, right, Rachna Shroff, MD, FASCO, organized the first Hepato Pancreatico-Biliary CME Symposium featuring, center, Matthew H.G. Katz, MD, CMQ, FACS, FASCO.
The University of Arizona College of Medicine – Tucson hosted the inaugural Hepato Pancreato-Biliary CME Seminar on Sept. 7 in the college’s Social Hall.
The event, good for 7.75 AMA PRA Category 1 Credits™, drew about 50 general surgeons, oncologists, gastroenterologists, primary care physicians, and HPB specialists who care for these patients to the daylong event.
The keynote speaker was Matthew H.G. Katz, MD, CMQ, FACS, FASCO, a professor of surgical oncology and the department chair of the Department of Surgical Oncology at the University of Texas MD Anderson Cancer in Houston.
Cancer center presenters (and their topics) included:
- Junaid Arshad, MD, MS, assistant professor, Division of Hematology & Oncology | “Neuroendocrine tumors of the pancreas” and “Advances in the Management of Gastrointestinal Stromal Tumors”
- Joshua Melson, MD, professor, Division of Gastroenterology & Hepatology, and Cancer Center director, high-risk clinic for gastrointestinal cancers | “Genetic screening and high-risk surveillance programs for pancreatic cancer”
- Aaron J. Scott, MD, associate professor, Division of Hematology & Oncology, and Cancer Center co-leader, Clinical and Translational Oncology Program | “Advances in gastric cancer: neoadjuvant therapy, radiation, and timing of surgical resection” and panel moderator, “Complex liver metastases in colorectal cancer”
- Rachna T Shroff, MD, MS, FASCO, professor and chief, Division of Hematology & Oncology, and Cancer Center interim clinical affairs director and clinical investigations director | “Advances in chemotherapy and immunotherapy for unresectable cholangiocarcinoma” and Pancreatic Cancer Panel moderator
Oleh Haluszka, MD (pictured 2nd from left in photo), professor and associate chief in the Division of Gastroenterology & Hepatology, also was a panelist in two sessions, one involving “Difficult Gallbladder and Bile Duct Injuries” and the other “Pancreatic Cancer, Pancreatic Cystic Lesions, and Pancreatic Neuroendocrine Tumors.”
Leading experts in the fields of HPB surgery, medical oncology, surgical oncology, interventional gastroenterology, and interventional radiology offered their expertise on multidisciplinary management of the difficult gallbladder, bile duct injuries, pancreatic cancer, acute and chronic pancreatitis, benign and malignant liver masses, and gastroesophageal cancers, with multidisciplinary case discussions.
See a mini-photo gallery at the original story link below.